About this resource

    Type of resources
    Reading
    Education level(s)
    College / Upper Division (Undergraduates), Graduate / Professional
    Primary user(s)
    Student, Teacher
    Subject area(s)
    Law, Life Science
    Language(s)
    English
    Cluster
    Academic Structures and Institutions, Ways of Working
    Last updated
    19 December 2024
    Reading

    A Public Option for Clinical Trials? Lessons from Convalescent Plasma

    By Victor Roy, Joseph S, Reshma Ramachandran

    Open this resource

    Level College / Upper Division (Undergraduates), Graduate / Professional · For Student, Teacher · Language English

    Abstract

    The case of clinical trials for convalescent plasma during COVID-19 illustrates important lessons for realizing public sector approaches to biomedical research and development. These lessons, centering on mission, transparency, and spillover effects, can be translated to wider efforts to develop a “public option” for clinical trials.

    Keywords COVID-19 · Plasma · Public sector